Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | AKT1 | P31749 | 2/20 | 0.40 |
| ▸ | GLS | O94925 | 1/20 | 0.40 |
| ▸ | RORC | P51449 | 1/20 | 0.38 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.37 |
| ▸ | CTSL | P07711 | 2/20 | 0.37 |
| ▸ | CTSB | P07858 | 2/20 | 0.37 |
| ▸ | CTSS | P25774 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | MMP13 | P45452 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5033940 | 0.87 | NR1D1 (0.36) | AKT1CTSLCTSBCTSSATM | |
| SCHEMBL5035679 | 0.84 | NR1D1 (0.52) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL5032659 | 0.83 | PPARG (0.40) | PPARGPPARAGLSCYP17A1MMP1 | |
| SCHEMBL8090953 | 0.82 | ATM (0.39) | AKT1CTSLCTSBCTSSATM | |
| SCHEMBL7570965 | 0.75 | AKT1 (0.50) | AKT1CTSLCTSBCTSS | |
| SCHEMBL30915258 | 0.75 | AKT1 (0.50) | AKT1CTSLCTSBCTSS | |
| SCHEMBL5374479 | 0.75 | CTSS (0.38) | CTSS | |
| SCHEMBL3748687 | 0.74 | NR1D1 (0.36) | CTSS | |
| SCHEMBL8091529 | 0.74 | CTSS (0.39) | CTSS | |
| SCHEMBL7562431 | 0.74 | AKT1 (0.49) | AKT1CTSLCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080176339-A1 | NEUTRAL LABELING REACTANTS AND CONJUGATES DERIVED THEREOF | WALLAC OY (FI) | 2008-07-24 | — | — | US | disclosed |
| US-20080176339-A1 | NEUTRAL LABELING REACTANTS AND CONJUGATES DERIVED THEREOF | WALLAC OY (FI) | 2008-07-24 | — | — | US | disclosed |
| US-20080176339-A1 | NEUTRAL LABELING REACTANTS AND CONJUGATES DERIVED THEREOF | WALLAC OY (FI) | 2008-07-24 | — | — | US | disclosed |
| US-20070166228-A1 | Neutral labeling reactants and conjugates derived thereof | WALLAC OY (FI) | 2007-07-19 | — | — | US | disclosed |
| US-20070166228-A1 | Neutral labeling reactants and conjugates derived thereof | WALLAC OY (FI) | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070166228-A1 | Neutral labeling reactants and conjugates derived thereof | NAAA, DNPEP, PAM | PPARG 1303/4885PPARA 1351/4885AKT1 3876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.